Corbus Pharmaceuticals Inc.

This study is testing a new drug called CRB-701 for people with advanced solid tumors that have a specific protein called nectin-4. Researchers want to find the safest and most effective dose and see which types of cancer respond best to the treatment. Participants will receive t…

This is an early-stage study to test a new daily pill called CRB-913 for weight loss in people with obesity. The main goals are to see if the drug is safe, how the body processes it, and if it helps reduce body weight. About 252 participants will take either the drug or a placebo…